Updated:24 May 2013 03:40:00 PM(IST)
Sensex19704.33
30.00 0.15%
Nifty5983.55
16.50 0.28%
Midcap6387.13
23.31 0.37%
Smallcap5992.46
18.01 0.30%
Dr Reddys Laboratories Ltd :
ISIN: INE089A01023 | NSE: DRREDDY | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 500124 | Comments
| Price Information | |
| • Open | 2062.80 |
| • High | 2071.75 |
| • Low | 2055.00 |
| • Previous Close | 2051.05 |
| • Shares Traded | 255214 |
| • 52 Wk High Price | 2150.90 |
| • 52 Wk High Date | 13-05-2013 |
| • 52 Wk Low Price | 1528.00 |
| • 52 Wk Low Date | 19-06-2012 |
| • Face Value | 5.00 |
| Fundamentals | |
| • Market Capital (Rs.cr) | 34924.30 |
| • EPS (Rs.)(TTM) | 74.50 |
| • P/E Ratio(TTM) | 27.60 |
| • Book Value (Rs.) | 448.30 |
| • Price to Book Value | 4.59 |
| • Equity (Rs.cr.) | 84.91 |
| • Traded Value (Rs.lac) | 649.96 |
| Corporate Actions | |
| Ex-Date | Purpose (Rs.) |
| 2011-03-17 | 6 Bonus Debentures for 1 Equity Shares (0) |
| 2011-06-30 | 225% Final Dividend (11.25) |
| 2012-06-28 | 275% Final Dividend (13.75) |
| Index Names | |
| • BSE-100 | |
| • BSE-200 | |
| • BSE-500 | |
| • BSE HC | |
| • S&P CNX Nifty | |
| Related Companies | ||
| Stock Name | Price | |
| CIPLA | 408.25 | |
| JBCHEPHARM | 82.65 | |
| JAYANTVITAMINS | 3.00 | - |
| MERIND | 200.00 | - |
| PIRHEALTH | 557.75 | |
| RANBAXY | 390.30 | |
| UNICHEMLAB | 170.35 | |
| ALEMBICLTD | 19.20 | |
| LYKALABS | 9.57 | |
| TTKHEALTH | 633.60 | |
| Share Tips for Dr Reddys Laboratories Ltd |
| Market outlook : After flat open, Nifty (09:02AM, May 24 '13) |
| Intraday trading calls : FII BOUGHT 665 (08:32AM, May 22 '13) |
| DRREDDY CALL>>>>>>>>>>>>>>>>>>>>>>>>>> (10:45AM, May 20 '13) |
| Sell Drreddy cmp 2099 future, sl 2120 (09:30AM, May 17 '13) |
| BIG BIG BLASTING GAINS DAILY FOR MORE (03:11PM, May 15 '13) |
| Mutual funds holding in Dr Reddys Laboratories Ltd |
| SBI Magnum Tax Gain Scheme 93 - Growth |
| Sundaram BNP Paribas Select Midcap - Growth |
| Sundaram BNP Paribas Taxsaver - (Open Ended Fund) - Growth |
| HDFC Equity Fund - Growth |
| Birla Sun Life Mid Cap Fund - Plan A - Growth |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| • Year End | Mar, 2013 | Mar, 2013 | Mar, 2013 |
| • Sales (Rs.cr) | 2233.30 | 8244.67 | 8244.67 |
| • Net Profit (Rs.cr) | 378.15 | 1265.47 | 1265.47 |
| • Net Profit Var (%) | 79.00 | 40.00 | 40.00 |
| • EPS (Rs) | - | 74.50 | 74.50 |
| • P/E Ratio | - | 27.60 | 27.60 |
| • Operating Profit Margin | - | 24.10 | - |
| • CPS (Rs.) | - | - | 92.90 |
| • P/C Ratio | - | - | 22.10 |
| • Div% | - | - | 300.00 |
Gross Deliverables
Date
Del. Shares
Trd. Qty.
Del.(%)
Del. Value
Turnover
21-05-2013
6740
20904
32.24
13610756
42401.60
20-05-2013
4127
16387
25.18
8450239
33863.30
17-05-2013
1844
10920
16.89
3831187
22750.50
13-05-2013
9453
42766
22.10
19671220
90519.00
11-05-2013
5854
13794
42.44
12240714
28694.20
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Dr Reddys Laboratories Ltd
©2011 Appuonline.com